Search by Drug Name or NDC

    NDC 63459-0912-36 GRANIX 480 ug/.8mL Details

    GRANIX 480 ug/.8mL

    GRANIX is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cephalon, LLC. The primary component is FILGRASTIM.

    Product Information

    NDC 63459-0912
    Product ID 63459-912_6c844d2a-1b12-4434-a915-dad9ad4b094f
    Associated GPIs 8240152070E540
    GCN Sequence Number 071654
    GCN Sequence Number Description tbo-filgrastim SYRINGE 480MCG/0.8 SUBCUT
    HIC3 N1C
    HIC3 Description LEUKOCYTE (WBC) STIMULANTS
    GCN 35576
    HICL Sequence Number 040426
    HICL Sequence Number Description TBO-FILGRASTIM
    Brand/Generic Brand
    Proprietary Name GRANIX
    Proprietary Name Suffix n/a
    Non-Proprietary Name tbo-filgrastim
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 480
    Active Ingredient Units ug/.8mL
    Substance Name FILGRASTIM
    Labeler Name Cephalon, LLC
    Pharmaceutical Class Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125294
    Listing Certified Through 2024-12-31

    Package

    NDC 63459-0912-36 (63459091236)

    NDC Package Code 63459-912-36
    Billing NDC 63459091236
    Package 5 SYRINGE, GLASS in 1 CARTON (63459-912-36) / .8 mL in 1 SYRINGE, GLASS (63459-912-18)
    Marketing Start Date 2015-03-02
    NDC Exclude Flag N
    Pricing Information N/A